Overview
About the program
The Health Sector Transformation Program, part of Saudi Arabia’s Vision 2030, aims to improve access to healthcare, modernize facilities and equipment, and enhance the role of private-sector investment. Saudi Arabia’s healthcare system is being transformed to meet the needs of every member of society.
This creates significant opportunities and challenges for healthcare leaders, pharmaceutical executives, policymakers and regulators: improving population health, enhancing healthcare quality, strengthening private-sector participation, and building a sustainable, innovative and internationally competitive healthcare and pharmaceutical ecosystem.
Saudi Public Health and Pharmaceutical Policy is an executive education program that equips senior decision-makers in the public and private sectors with the strategic knowledge, policy expertise and leadership capabilities needed to put these changes into practice. It is offered by KAUST Academy with Riyadh Chamber and UCL Global Business School for Health, and is aligned with Saudi Vision 2030 and the Health Sector Transformation Program.
Aligned with Vision 2030
Built around the Health Sector Transformation Program and the priorities of Saudi healthcare.
Riyadh, London and KAUST
Three full-time, in-person weeks in Saudi Arabia and the United Kingdom.
For senior leaders
Leaders from healthcare, pharmaceuticals, policy and regulation, in the public and private sectors.
In partnership
KAUST Academy, Riyadh Chamber and UCL

The program is delivered by KAUST Academy in partnership with Riyadh Chamber, with its international week hosted by UCL Global Business School for Health in London.
The program
Program structure
Three weeks, five days a week, full time and in person: one week in Riyadh, one in London and one at KAUST.
Week 1 · Third week of December 2026
Riyadh
In person
The program opens in Riyadh with the Saudi health and pharmaceutical policy landscape and the priorities of the Health Sector Transformation Program.
Week 2 · Last week of January 2027
UCL Global Business School for Health, London
International week
An international week at UCL Global Business School for Health, benchmarking Saudi health and pharmaceutical policy against international practice.
Week 3 · Last week of February 2027
KAUST, Thuwal
In person
The program closes at KAUST, turning national policy objectives into practical strategies for participants’ organizations.
Learning objectives
What you’ll learn
Policy into strategy
Explore where health policy, public health priorities, pharmaceutical industry development and strategic leadership meet, with particular emphasis on translating national policy objectives into practical strategies.
Policies in practice
Apply the policies driving the Saudi healthcare transformation: personalization, digitalization and the restructuring of the healthcare system.
Investment and innovation
Analyze investment opportunities and challenges in the Saudi healthcare and pharmaceutical sectors that encourage innovation and improve population health outcomes.
Who it’s for
Who should attend
Leaders in the health sectorPeople in leadership roles in health: healthcare leaders, pharmaceutical executives, policymakers and regulators, and business owners and executives in the public and private sectors.
A bachelor’s degreeAt minimum. Experience in health, pharmaceuticals, insurance or investment is an advantage.
Available for all three weeksThe program is full time and in person, and runs in English.
Costs
Program costs
There is no program fee. Participants cover their own flights and accommodation for the three weeks, as well as any visa they need for the United Kingdom.
Registration
How to register
Register online
Fill in the registration form with your professional background and your reasons for joining.
Review
Places are limited. The program team reviews each registration.
Confirmation
Selected participants are contacted by email with the program details.
Questions
FAQs
Who is the program for?
Senior decision-makers with leadership roles in the health sector: healthcare leaders, pharmaceutical executives, policymakers and regulators, in the public and private sectors.
Where and when does it take place?
Over three in-person weeks: Riyadh in the third week of December 2026, UCL Global Business School for Health in London in the last week of January 2027, and KAUST, Thuwal, in the last week of February 2027.
Is the program full time?
Yes. Each week runs five days, full time, in person.
Is there a program fee?
No. Participants cover their own flights, accommodation and any visa for the United Kingdom.
What language is the program taught in?
English.
How do I register?
Through the registration form. The program team reviews each registration and contacts the selected participants.




